Introduction. Systemic perioperative vancomycin may not provide sufficient prophylactic target-site concentrations in the prevention of prosthetic joint infections. Intraosseous vancomycin potentially provides high target-site concentrations. The objective of the present study was to evaluate the local bone and tissue concentrations following tibial intraosseous vancomycin administration in a porcine model. Methods. Eight pigs received 500 mg diluted vancomycin (50 mg/mL) through an intraosseous cannula into the proximal tibial cancellous bone. No tourniquet was applied. Microdialysis was applied for sampling of vancomycin concentrations in adjacent tibial cancellous bone, in cortical bone, in the intramedullary canal of the diaphysis, in the synovial fluid of the knee joint, and in the subcutaneous tissue. Plasma samples were obtained as a systemic reference. Samples were collected for 12 h. Results. High vancomycin concentrations were found in the tibial cancellous bone with a mean peak drug concentration of 1236 (range 28–5295) , which remained high throughout the sampling period. The mean (standard deviation) peak drug concentration in plasma was 19 (2) , which was obtained immediately after administration. Peak drug concentration, time to peak drug concentration, and area under the concentration–time curve were within the same range in the intramedullary canal, the synovial fluid of the knee, and the subcutaneous tissue. Conclusion. Tibial intraosseous administration of vancomycin provided high concentrations in tibial cancellous bone throughout a 12 h period but with an unpredictable and wide range of peak concentration. The systemic absorption was high and immediate, thus mirroring an intravenous administration. Low mean concentrations were found in all the remaining compartments.
3 November 2021 in Journal of Bone and Joint Surgery
Background: Peri and postoperative antibiotics are key adjuvant treatment tools in the management of periprosthetic joint infection (PJI). The aim of this study was to evaluate the effect of rifampicin on the area under the moxifloxacin concentration-time curve from 0 to 24 hours (AUC0-24) in the synovial fluid of the knee joint, tibial bone, and adjacent subcutaneous tissue under steady-state conditions using microdialysis in a porcine model. Methods: Twenty female pigs were randomized to receive oral treatment with moxifloxacin monotherapy (Group A, n = 10) of 400 mg once daily for 3 days or a combination therapy (Group B, n = 10) of 400 mg of moxifloxacin once daily for 3 days and 450 mg of rifampicin twice daily for 7 days. Microdialysis was used for sampling the synovial fluid of the knee joint, tibial cancellous and cortical bone, and adjacent subcutaneous tissues. Plasma samples were taken as a reference. Measurements were obtained for 24 hours. Results: Coadministration of moxifloxacin and rifampicin resulted in reductions of the moxifloxacin AUC0-24 in all targeted tissue compartments by 67% to 85% (p < 0.05). The corresponding change in plasma was 20% (p = 0.49). For both groups, the tissue penetration (the ratio of tissue free fraction AUC0-24 to plasma free fraction AUC0-24 [fAUCtissue/fAUCplasma]) was incomplete in all investigated compartments. The highest moxifloxacin tissue penetration was in the knee joint synovial fluid: 0.59 (Group A) and 0.24 (Group B). The lowest tissue penetration was in the cortical bone: 0.17 (Group A) and 0.03 (Group B). Conclusions: We found a significant reduction of the moxifloxacin concentration, expressed as the AUC0-24, in tissues relevant to acute PJI treatment when coadministered with rifampicin. Clinical Relevance: The concentrations within the targeted tissue compartments were reduced significantly more than the concentrations in plasma, which may be particularly important as plasma concentrations are used in clinical practice to assess moxifloxacin treatment sufficiency.
Co-administration of meropenem and vancomycin has been suggested as a systemic empirical antibiotic treatment of pyogenic spondylodiscitis. The aim of this study was, in an experimental porcine model, to evaluate the percentage of an 8-h dosing interval of co-administered meropenem and vancomycin concentrations above the relevant minimal inhibitory concentrations (MICs) (%T>MIC) in spinal tissues using microdialysis. Eight female pigs (Danish Landrace breed, weight 78–82 kg) received a single-dose bolus infusion of 1000 mg of meropenem and 1000 mg vancomycin simultaneously before microdialysis sampling. Microdialysis catheters were applied in the third cervical (C3) vertebral cancellous bone, the C3–C4 intervertebral disc, paravertebral muscle, and adjacent subcutaneous tissue. Plasma samples were obtained for reference. The main finding was that for both drugs, the %T>MICs were highly reliant on the applied MIC target, but were heterogeneous across all targeted tissues, ranging from 25–90% for meropenem, and 10–100% for vancomycin. For both MIC targets, the highest %T>MIC was demonstrated in plasma, and the lowest %T>MIC was demonstrated in the vertebral cancellous bone for meropenem, and in the intervertebral disc for vancomycin. When indicated, our findings may suggest a more aggressive dosing approach of both meropenem and vancomycin to increase the spinal tissue concentrations to treat the full spectrum of potentially encountered bacteria in a spondylodiscitis treatment setting.
10 December 2025 in Journal of Bone and Joint Infection
Introduction: Fasciocutaneous and muscle flaps are used for the reconstruction of lower-limb composite bone and soft-tissue defects. Flap-mediated contributions to the healing microenvironment are less described. We present a comparative porcine model with a standardized bone and soft-tissue defect reconstructed by fasciocutaneous or muscle flaps and characterize the early tissue response following flap transfer. Methods: Using both hindlimbs of 10 female pigs, symmetrical tibial bone and soft-tissue defects were created and reconstructed with fasciocutaneous flaps (n= 8) or muscle flaps (n= 8) or were closed primarily (n= 4, controls). Interstitial metabolites (glucose, lactate, and pyruvate) were sampled by microdialysis from flap and control tissue for 11 h before, during, and after 60 min of global flap ischemia (simulating free flap transfer). Flap histopathology was graded for the acute inflammatory response. Results: All pigs and flaps completed the study. Both flaps exhibited ischemia–reperfusion-induced metabolic alterations relative to the control tissue. The lactate-to-pyruvate ratio increased 3-fold in muscle flaps during ischemia, while fasciocutaneous flaps showed lactate and a lactate-to-pyruvate ratio that were 1.5-fold higher during reperfusion. Histopathology demonstrated early cellular activity at the bone lesion–flap interface in both flap types, with greater oedema and hyperaemia in fasciocutaneous flaps. Conclusion: We established a reproducible comparative large-animal model integrating interstitial metabolite and histopathological analyses to describe early flap-mediated tissue responses. Early flap-specific differences in metabolic and structural patterns may influence flap function and the healing microenvironment. The model provides a basis for evaluating clinically relevant ortho-plastic outcomes.
13 October 2026 in European Journal of Plastic Surgery
Introduction & Aim: Effective management of complex tissue defects and bone infections relies on surgical soft-tissue reconstruction combined with adequate local antibiotic delivery. However, antibiotic delivery within the reconstructed combined bone–soft-tissue unit remains poorly characterised. Methods: In a controlled large-animal model, combined bilateral tibial bone and soft-tissue defects were created in ten pigs and reconstructed with muscle flaps (n=8), fasciocutaneous flaps (n=8), or direct closure (n=4, controls). Both flaps underwent 60 minutes of arteriovenous clamping to simulate free flap ischaemia. Single intravenous infusions of meropenem (1000 mg) and vancomycin (2000 mg) were administered. Interstitial concentrations were obtained by microdialysis in flap or subcutaneous tissue (controls), at the flap–bone interface, and in underlying cancellous bone. Antibiotic exposure was quantified as the area under the concentration–time curve (AUC0-450). Plasma samples served as a systemic reference. Sampling continued for 450 minutes. Results: For both antibiotics, no differences were observed between flap types or direct closures at the flap–bone interface or in cancellous bone. In contrast, differences were observed within flap tissues. Compared with muscle flaps, fasciocutaneous flaps achieved 1.70-fold (95% CI 1.27–2.29) and 1.29-fold (95% CI 1.06–1.58) higher exposure for meropenem and vancomycin, respectively. Direct closure resulted in the highest within soft-tissue exposure. Conclusions: Early postoperative antibiotic delivery within the reconstructed surgical site was both tissue and drug-dependent. Although exposure at the flap–bone interface and cancellous bone were comparable across flap types and direct closures, flap composition significantly influenced within-flap exposures. These findings challenge assumptions about flap-mediated antibiotic delivery, and the model provides a reproducible mechanism for investigating systemic and local antibiotic strategies in the management of complex tissue defects and bone infections. Acknowledgements: This study was funded by unrestricted grants from the Vissing Foundation, the Laege Sofus Carl Emil Friis and hustru Olga Doris Friis' Grant, the Riisfort Foundation, and the Department of Clinical Medicine, Aarhus University.